- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05296343
Guidelines for Parental Involvement in the Care of Suicidal Youth (S-Urg-Quali)
Developing Guidelines for Parental Involvement in the Emergency Care of Suicidal Adolescents and Young Adults: a Qualitative Study
Parents occupy a central place in the emergency care of suicidal adolescents and young adults. However, from 15 to 25yo, three different administrative situations exist in France:
- <16yo: admission to a child ED by a team trained to receive the youngest patients.
- 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
- >18yo: admission to an adult ED by team.
Laying on qualitative observational protocol and a Delphi approach, this study will explore the perspective of adolescents and young adults following a suicidal attempt, the perspective of their parents, and the perspective of their healthcare professionals to build guidelines for parental involvement in care of suicidal youths.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Suicide is the second leading cause of death among 15-25 year olds, with the highest rate of hospitalization for SC of any age group. The psychopathology of suicidal behavior in adolescents and young adults (AYA) is homogeneous: risk factors, precipitating factors, representations. Parents occupy a central place in care. They are i) involved in the care decision; ii) actively involved in care; and ii) a source of motivation for trust and adherence to care.
However, if the psychopathology of suicidal crisis is homogeneous, the transition between pediatric and adult care implies very different management in the emergency department (ED). In France, three situations can be described:
- <16yo: admission to a child ED by a team trained to receive the youngest patients.
- 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
- >18yo: admission to an adult ED by team devoted to adult care, no right to contact the parents in case of patient opposition.
- Before 16 years of age: admission to the children's UAS, care by a team trained to receive the youngest patients.
- 16-18 years: admission to the adult UAS, care by adult professionals, clinical and legal particularities of care for minors.
- After 18 years old: admission to adult UAS, legal constraints of the adult care setting.
The objectives of this qualitative observational study is to build guidelines for the involvement of the parents in the care in these three situations.
The study will include adolescents and young adults from the three situations, their parents and the professionals who take care of them. Individual semi-structured interviews will be organized to collect their experiences. Qualitative analyses will be conduct, following Interpretative Phenomenological Analysis. A pre-approved guideline will be construct and a Delphi approach will be conducted to approved the final version of the guideline.
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
-
Clermont-Ferrand, France, 63000
- CHU de Clermont-Ferrand
-
Chercheur principal:
- Jonathan Lachal
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
Adolescents and Young adults
- Admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team
Parents
- Parents of the included youths >18y
Healthcare professionals
- >18y
- Working in ED
- Usually taking care of suicidal youths
All the participants
- French speaking
- Affiliation to a social security regime
- Participation agreement
Exclusion Criteria:
All the participants
- Present an acute somatic or psychiatric disease which may hinder the well organization of the interview
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Adolescents and young adults
Boys and girls from 15 to 25 years old admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team
|
|
Parents
One or the two parents of the included adolescents and young adults
|
|
Healthcare professionals
Professionals working in one emergency departments of the inclusion centers and who usually take care of suicidal adolescents and young adults
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Developing guidelines defining the role of parents in the medical decision and the care of the youths
Délai: Day 1
|
Thematic framework summarizing the perspectives of three groups of participants.
|
Day 1
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Describing each context of care
Délai: Day 1
|
Qualitative description of each of the three context of care (<16y, 16-18y, >18y)
|
Day 1
|
|
Describing expectations from each group
Délai: Day 1
|
Qualitative description of each of the three participant groups (adolescents and young adults, parents, professionals)
|
Day 1
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Jonathan Lachal, University Hospital, Clermont-Ferrand
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AOI 2021 LACHAL
- 2021-A03244-37 (Autre identifiant: ANSM)
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .